NeuroVia, Inc.

Financings Third-quarter 2017 biopharma financing reached $12.5 billion, just a 6% decrease from the previous quarter's $13.4 billion. ( See Exhibit 1. ) The most money was raised in the follow-on pub

Eli Lilly & Co. has promoted Josh Smiley to senior vice president and chief financial officer (CFO); he will also become a member of Lilly's executive committee. Derica Rice , Lilly's current

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar